Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
about
Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injuryPolyamines and cancer: implications for chemotherapy and chemopreventionRetinovascular physiology and pathophysiology: new experimental approach/new insightsMechanistic studies of the yeast polyamine oxidase Fms1: kinetic mechanism, substrate specificity, and pH dependence.Regulated expression of an essential allosteric activator of polyamine biosynthesis in African trypanosomesIn vitro evaluation of ESE-15-ol, an estradiol analogue with nanomolar antimitotic and carbonic anhydrase inhibitory activityDefining the role of polyamines in colon carcinogenesis using mouse models.Polyamines are traps for reactive intermediates in furan metabolism.Vulnerability of the retinal microvasculature to hypoxia: role of polyamine-regulated K(ATP) channels.Polyamine-regulated translation of spermidine/spermine-N1-acetyltransferase.Gene expression analysis of pig cumulus-oocyte complexes stimulated in vitro with follicle stimulating hormone or epidermal growth factor-like peptides.γ-glutamyl Spermine Synthetase PauA2 as a potential target of antibiotic development against Pseudomonas aeruginosa.In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells.New tricks from an old dog: mitochondrial redox signaling in cellular inflammation.Current status of the polyamine research fieldPolyamine biosynthesis as a target to inhibit apoptosis of non-tumoral cells.Implication of the polyamine system in mental disorders.Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator.Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages.Mammalian polyamine metabolism and functionPolyamine catabolism and disease.Modulation of polyamine metabolic flux in adipose tissue alters the accumulation of body fat by affecting glucose homeostasis.Polyamine catabolism: target for antiproliferative therapies in animals and stress tolerance strategies in plants.Polyamine depletion enhances the roscovitine-induced apoptosis through the activation of mitochondria in HCT116 colon carcinoma cells.The polyamine analogue N1,N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines.Effect of the polyamine analogue N1,N11-diethylnorspermine on cell survival and susceptibility to apoptosis of human chondrocytes.Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells.pH dependence of a mammalian polyamine oxidase: insights into substrate specificity and the role of lysine 315.Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues.Mechanistic studies of para-substituted N,N'-dibenzyl-1,4-diaminobutanes as substrates for a mammalian polyamine oxidase.Difluoromethylornithine inhibits hypertrophic, pro-fibrotic and pro-apoptotic actions of aldosterone in cardiac cells.Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites.Functional K(ATP) channels in the rat retinal microvasculature: topographical distribution, redox regulation, spermine modulation and diabetic alteration.Induction of the pho regulon and polyphosphate synthesis against spermine stress in Pseudomonas aeruginosa.Cellular and Animal Model Studies on the Growth Inhibitory Effects of Polyamine Analogues on Breast Cancer.Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus.Polyamine Metabolism and Oxidative Protein Folding in the ER as ROS-Producing Systems Neglected in Virology.
P2860
Q26830785-835F0FD8-6548-43C3-AB3C-C9112E230174Q26864516-D080546A-366A-4632-886F-5D5967C262E7Q27012985-E2091035-70C0-4577-808C-4E64652539A5Q27938656-A3847FE4-77CF-4613-974C-8BFCF0CB3068Q28473800-7D4C3949-91F8-4556-A452-5AA74727E5B2Q28484595-FF70FAF4-8CC5-4FD7-A7C7-9163D4127CCAQ35064943-3BDD0188-2E8C-4613-A9A8-129607936FFFQ35566420-453D4C60-897D-4251-88A0-C40C29A7D9DAQ35647413-422C20D8-56D9-4C3E-87F4-8FFAF289E648Q35867930-6AA5BD83-8F01-42A0-86CB-2F5EEB5C615EQ36131060-4E512EEE-633D-49B5-A1D3-3BEE5F746950Q36276822-01EB8312-D450-4FBC-A62D-9669879267A8Q36790732-E2B7E12A-064F-4AE7-83A2-F9098B6C95B1Q36834142-19AD7A71-164E-4E29-8C23-12C1692C2BD8Q36838564-C06144FD-B71B-422F-BB3C-BA9978FA9DAAQ36853226-DB9968BE-6A0C-47CC-860C-461EA58F84DDQ37106189-CF68A2A3-F817-4D3D-ACEF-3F4D2E45E509Q37113086-FE14705C-C8B1-4A56-9098-C243417C056AQ37134470-71596331-AF05-4766-B400-48757650EBBFQ37365983-69DFF542-6BF0-45E1-8DF2-826E1E004E0CQ37372519-7A545A89-24C0-4720-AD4D-BCA506ABCE51Q37532341-66241FB1-DE6A-4F0B-A790-92BDE7CE2433Q37923379-0E73B070-D55A-4CE1-9469-F7ADFB5C0E4BQ39496558-7CAF2B5D-C41D-454A-8184-0B5D9393FC46Q39903426-BC0D84F9-87A2-4E7C-A4DD-EB8955F970D6Q40019026-E80DFC22-5DBA-4CAF-B17C-D5116ED6F86DQ41347219-ACF7D2DE-D658-4C0F-9109-A10215DD95FAQ42567031-6BFDBB90-0E5E-4951-83A8-9033B039E2DFQ42705118-D07CBE17-F94F-4D42-BD5D-EA3CD1FE1971Q42948302-BFA52F08-E57A-4E02-A014-16E70C7FB815Q43230136-65BFFE90-7DD4-45BF-B1BD-3FD28BC975E6Q44582091-0F35FEBA-3BA9-49C6-9A32-C767C24604D1Q46086850-6A8FEAFD-A978-4B56-B41A-7AA32E1E0670Q48331805-48ACDFA1-285C-4749-B80B-BEB79275F590Q52658057-6FEAA729-8A70-49C3-8FD7-30850DDEFCCEQ54112990-6F3FF2FE-82F7-4419-8B23-480793BFFD19Q54232255-246A5F0D-40CE-4434-8D96-834CC2A973FB
P2860
Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
@ast
Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
@en
type
label
Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
@ast
Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
@en
prefLabel
Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
@ast
Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
@en
P2860
P356
P1476
Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?
@en
P2093
Robert A Casero
Yanlin Wang
P2860
P356
10.1093/JB/MVJ021
P577
2006-01-01T00:00:00Z